Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1944558558;58559;58560 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
N2AB1780453635;53636;53637 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
N2A1687750854;50855;50856 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
N2B1038031363;31364;31365 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
Novex-11050531738;31739;31740 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
Novex-21057231939;31940;31941 chr2:178594060;178594059;178594058chr2:179458787;179458786;179458785
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Ig-118
  • Domain position: 55
  • Structural Position: 139
  • Q(SASA): 0.1427
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1418076473 1.483 0.081 N 0.562 0.167 0.307016933798 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.9E-06 0
E/K rs1418076473 1.483 0.081 N 0.562 0.167 0.307016933798 gnomAD-4.0.0 4.79018E-06 None None None None N None 0 0 None 0 0 None 0 0 6.29684E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2555 likely_benign 0.1939 benign -0.782 Destabilizing 0.019 N 0.581 neutral N 0.518378093 None None N
E/C 0.8114 likely_pathogenic 0.7313 pathogenic -0.601 Destabilizing 0.958 D 0.697 prob.neutral None None None None N
E/D 0.2959 likely_benign 0.2871 benign -1.426 Destabilizing 0.042 N 0.482 neutral N 0.500659124 None None N
E/F 0.7888 likely_pathogenic 0.7107 pathogenic -0.245 Destabilizing 0.667 D 0.697 prob.neutral None None None None N
E/G 0.2296 likely_benign 0.1691 benign -1.193 Destabilizing None N 0.421 neutral N 0.451366454 None None N
E/H 0.4552 ambiguous 0.3748 ambiguous -0.774 Destabilizing 0.667 D 0.643 neutral None None None None N
E/I 0.4173 ambiguous 0.33 benign 0.356 Stabilizing 0.124 N 0.7 prob.neutral None None None None N
E/K 0.2052 likely_benign 0.1621 benign -1.178 Destabilizing 0.081 N 0.562 neutral N 0.456425557 None None N
E/L 0.4603 ambiguous 0.3649 ambiguous 0.356 Stabilizing 0.055 N 0.641 neutral None None None None N
E/M 0.5293 ambiguous 0.4277 ambiguous 0.877 Stabilizing 0.667 D 0.69 prob.neutral None None None None N
E/N 0.3978 ambiguous 0.3349 benign -1.539 Destabilizing 0.002 N 0.341 neutral None None None None N
E/P 0.9692 likely_pathogenic 0.9455 pathogenic -0.002 Destabilizing 0.364 N 0.641 neutral None None None None N
E/Q 0.1257 likely_benign 0.1076 benign -1.32 Destabilizing 0.301 N 0.593 neutral N 0.449942302 None None N
E/R 0.2875 likely_benign 0.2175 benign -0.967 Destabilizing 0.22 N 0.617 neutral None None None None N
E/S 0.2672 likely_benign 0.2118 benign -1.937 Destabilizing 0.005 N 0.303 neutral None None None None N
E/T 0.2556 likely_benign 0.1919 benign -1.6 Destabilizing None N 0.4 neutral None None None None N
E/V 0.2502 likely_benign 0.2036 benign -0.002 Destabilizing 0.042 N 0.634 neutral N 0.440994745 None None N
E/W 0.8686 likely_pathogenic 0.8057 pathogenic -0.163 Destabilizing 0.958 D 0.703 prob.neutral None None None None N
E/Y 0.6344 likely_pathogenic 0.5395 ambiguous -0.072 Destabilizing 0.667 D 0.688 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.